Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer

NCT00003009 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped Insufficient Accrual

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: aldesleukin

Sponsor

University of Southern California

Collaborators

[object Object]